Pegfilgrastim

Welcome to Dwaey, specifically on Pegfilgrastim page.
This medicine contains important and useful components, as it consists of
Pegfilgrastim is available in the market in concentration.

Generic Name of Pegfilgrastim - Learn More

Pegfilgrastim

Pegfilgrastim Precaution - What You Need to Know

Before starting Pegfilgrastim, it is essential for patients to consult with their healthcare provider to evaluate the benefits and risks of the medication. Pegfilgrastim is a granulocyte colony-stimulating factor (G-CSF) used to stimulate the production of white blood cells and is typically given to reduce the risk of infection in patients undergoing chemotherapy. The following precautions should be considered:

- Allergic Reactions: Severe allergic reactions, including anaphylaxis, have been reported with Pegfilgrastim. If symptoms of an allergic reaction (such as rash, itching, swelling, or difficulty breathing) occur, immediate medical attention is required.
- Bone Pain: Pegfilgrastim can cause bone pain due to the increased production of white blood cells. This pain can be severe, especially in the bones where the marrow is most active, and should be managed appropriately.
- Spleen Rupture: Although rare, splenic rupture has been observed in some patients. Patients should be monitored for symptoms like left upper abdominal pain, shoulder pain, or enlarged spleen.
- Sickle Cell Disease: Pegfilgrastim should be used cautiously in patients with sickle cell disease or other blood disorders, as it may lead to complications.
- Pregnancy and Breastfeeding: The safety of Pegfilgrastim during pregnancy is not well-established, so it should only be used during pregnancy if the benefits outweigh the risks. It is also not known if it passes into breast milk, so breastfeeding mothers should consult their healthcare provider before use.
- Severe Kidney or Liver Disease: Caution is recommended in patients with severe renal or hepatic impairment, as the drug’s safety and efficacy have not been fully established in these populations.

Pegfilgrastim Indication - Uses and Benefits

Pegfilgrastim is used primarily to support the immune system in cancer patients undergoing chemotherapy by reducing the risk of infections due to neutropenia (low white blood cell count). It is indicated for the following:

- Chemotherapy-Induced Neutropenia: Pegfilgrastim is used in patients undergoing chemotherapy to reduce the risk of febrile neutropenia (fever and low white blood cell count), which is a common side effect of chemotherapy. This drug helps stimulate the production of neutrophils (a type of white blood cell) to fight infections.
- Bone Marrow Recovery: It is also used to help stimulate bone marrow recovery in patients who have undergone bone marrow transplantation or who suffer from other conditions that lead to low white blood cell counts.
- Other Conditions: It may be used in the treatment of certain other disorders that involve low white blood cell counts, although its primary indication remains chemotherapy-induced neutropenia.

Pegfilgrastim Contraindications - Important Warnings

Pegfilgrastim is contraindicated in the following situations:

- Hypersensitivity: Any patient who has a known hypersensitivity to Pegfilgrastim or filgrastim (the non-pegylated version of the drug) should avoid using this medication.
- Serious Allergic Reactions: If a patient has previously had a severe allergic reaction (including anaphylaxis) to Pegfilgrastim or any of its components, it should not be administered.
- Myeloid Disorders: Pegfilgrastim should not be used in patients with myeloid leukemia (a type of blood cancer), as it can exacerbate the disease or interfere with treatment.
- Pregnancy: Although not absolutely contraindicated, Pegfilgrastim should only be used during pregnancy if absolutely necessary. It is classified as Category C, meaning risk cannot be ruled out, and its use during pregnancy should be thoroughly discussed with a healthcare provider.
- Active Infections: Pegfilgrastim should not be used in patients with active infections until the infection has been appropriately treated, as the drug may increase the risk of infection under such conditions.

Pegfilgrastim Side Effects - What to Expect

Pegfilgrastim, like all medications, can cause side effects. While it is generally well-tolerated, potential side effects include:

- Common Side Effects:
- Bone pain is one of the most frequently reported side effects, occurring in up to 25% of patients. It can range from mild to severe and may require pain management.
- Fatigue or general feelings of tiredness.
- Injection site reactions: Redness, pain, or swelling at the injection site.
- Headache and muscle aches.
- Fever may occur in some patients.
- Nausea and vomiting.

- Serious Side Effects:
- Splenic rupture: Although rare, splenic rupture has been reported in some patients, often leading to symptoms like left upper abdominal pain, shoulder pain, and dizziness. This requires immediate medical attention.
- Severe allergic reactions: Including anaphylaxis (swelling of the face, lips, or throat, difficulty breathing).
- Sickle cell crisis in patients with sickle cell disease, which may cause acute pain or other complications.
- Leukocytosis (an abnormally high white blood cell count), which may result in complications if not monitored appropriately.
- Capillary leak syndrome: A rare, but serious condition where fluid leaks from blood vessels into surrounding tissues, leading to swelling and low blood pressure.

Pegfilgrastim Pregnancy Category ID - Safety Information

3

Pegfilgrastim Mode of Action - How It Works

Pegfilgrastim works by stimulating the bone marrow to produce more neutrophils, a type of white blood cell essential for fighting infections. It is a pegylated version of filgrastim, which means it has a polyethylene glycol (PEG) molecule attached to it, which increases its half-life and allows for less frequent dosing. Pegfilgrastim works through the following mechanisms:

- Activation of Granulocyte Colony-Stimulating Factor (G-CSF) receptors: Pegfilgrastim binds to and activates G-CSF receptors on the surface of hematopoietic stem cells, which then stimulates the production and release of neutrophils into the bloodstream.
- Neutrophil Proliferation: Pegfilgrastim not only stimulates the production of neutrophils but also enhances the survival of neutrophils already in circulation, helping to prevent infections in patients with neutropenia (low white blood cell count).

Pegfilgrastim Drug Interactions - What to Avoid

Pegfilgrastim has a relatively low potential for drug interactions, but certain medications and conditions should be considered:

- Chemotherapy Agents: While Pegfilgrastim is used to help counteract the neutropenia caused by chemotherapy, its effects could potentially be altered by specific chemotherapy drugs. Close monitoring is essential to assess whether the desired neutrophil count is achieved.
- Cyclophosphamide: Some chemotherapy agents like cyclophosphamide may interact with Pegfilgrastim. Patients receiving both treatments should be monitored carefully for side effects, including neutropenia or the risk of other blood-related complications.
- Radiation: Pegfilgrastim should be used cautiously in patients undergoing radiation therapy, as its effects on bone marrow recovery may vary depending on radiation dose and treatment area.
- Lithium: Pegfilgrastim may interact with lithium, increasing white blood cell production. Close monitoring of blood counts is necessary when both drugs are used together.
- Vaccines: There are no specific contraindications for vaccines when using Pegfilgrastim, but live vaccines should generally be avoided during chemotherapy, as chemotherapy may suppress the immune system.

Pegfilgrastim Adult Dose - Recommended Dosage

The standard dose for Pegfilgrastim is typically a single subcutaneous injection of 6 mg once per chemotherapy cycle, usually given 24 hours after chemotherapy. It is important that the injection is administered under the supervision of a healthcare provider, as there may be variability in how each patient responds to the medication.

- For chemotherapy-induced neutropenia: Pegfilgrastim is usually given once per chemotherapy cycle, typically on the day after chemotherapy.
- For bone marrow recovery or other indications, dosing may vary depending on the specific treatment plan, but it generally follows a similar pattern of 6 mg once per cycle.

Pegfilgrastim Child Dose - Dosage for Children

The dosing of Pegfilgrastim in pediatric patients is similar to that for adults. The standard pediatric dose is also typically 6 mg per injection. However, the dose may vary depending on the child’s age, weight, and specific medical condition, particularly in those undergoing chemotherapy. For patients younger than 18 years, Pegfilgrastim should only be used under the supervision of a healthcare provider with expertise in pediatric oncology or hematology.

Pegfilgrastim Renal Dose - Dosage for Kidney Conditions

No significant renal dose adjustments are necessary for Pegfilgrastim in patients with mild to moderate renal impairment. However, its safety and efficacy in patients with severe renal impairment have not been well established, and caution should be exercised in such cases. It is recommended that renal function be monitored regularly.